共找到 20 项 “Novartis” 相关结果
- 全部分类
- 全部
- 文学
- 历史
- 哲学/宗教
- 法律
- 政治/社会
- 医学
- 教育/心理学
- 艺术/传媒
- 研究生考试
- 资格认证考试
- 公开课
- 语言
- 经济金融
- 管理学
- IT/计算机
- 自然科学
- 工学/工程
- 体育
- 行业资料
- 音乐
- 汽车机械制造
- 文档模板
- 创业
- 农学
- 生活
- 数据库教程
- 民族
Netter’s illustrated human pathology
作者: L. Maximilian Buja,Gerhard R. F. Krueger原著;Frank H. Netter绘图;崔全才主译
出版社:人民卫生出版社,2008
简介:《奈特病理学彩色图谱》主要内容:奈特博士于1906年生于美国纽约市。他曾在学生艺术联合会和美国国家设计院学习绘画艺术,后进入纽约大学医学院学习医学,于1931年获得医学博士学位。在学习期间,他的素描就引起了医学界的注意,并纷纷聘请他一些文章和著作绘制插图。在1933年成为职业外科医生后,奈特继续在业余时间从事绘画工作,但他最终放弃了医生的职业,全身心地投入到钟爱的绘画艺术中。在第二次世界大战期间,他在美国军队服役,退役后便开始了与CIBA制药公司(现为Novartis制药公司)的长期合作。长达45年的合作使他积累了宝贵的医学艺术财富,成为世界各国的医生和其他医务工作者十分熟悉的医学绘画艺术家。 2000年7月,Icon公司获得了奈特博士的图集,并根据新的资料对奈特博士的原作不断进行修正,并增补一些新的插图,而这些插图都是由接受过奈特博士风格训练的画家所制作的。 奈特博士的作品是用图画形象地传授医学知识的典范。l3卷《奈特医学图集》收入了奈特博士创作的20000多幅插图中的大部分,是最著名的世界医学巨著之一。《奈特人体解剖彩色图谱》于1989年首次出版,现已译为11种语言(中文版也已南人民卫生出版社出版),成为全世界医学及相关科学学生在学习中首选的解剖学图谱。 奈特博士的作品之所以受到人们的青睐,不仅由于其超常的美学水平,更重要的是其丰富的知识内涵。正如奈特博士于1949年所说,“……阐明主体是图画的根本目的和最高目标。作为医学艺术作品,不管绘制得多么美,艺术构思和主体表达多么巧妙,如果不能阐明其医学观点,就将失去价值。”奈特博士的绘画设计、对艺术的理解构想、观察和处理问题的方式,以及对事业的追求,全部淋漓尽致地表现在他的绘画作品中,使他的作品达到了艺术性和科学性的完美结合。
作者: Rosabeth
简介:
Rosabeth Moss Kanter on the answer to the global crisis ofbusiness and American-style capitalism.
Out of the ashes of conventional business models arises a set ofcompanies using their power not only for profits and sustainablegrowth but also social good.
If you think business corporations are doomed to be lumbering,bloated, and corrupt, think again.
Based on an extraordinary three-year investigation, interviewingmore than 350 key people at major companies around the world,Rosabeth Moss Kanter provides encouraging and astounding evidencethat this assumption is completely outdated. The businesses thatare agile, keeping ahead of the curve in terms of market changesand customer needs, are the businesses that are also progressive,socially responsible human communities.
Take IBM. When the tsunami and earthquake struck Asia, IBM didn’tjust cut a check for relief funds and call it a day. The companyused its technological expertise and skilled people to create whatgovernment and relief agencies could not: information systems toeffectively track relief supplies and reunite families. While IBMdid this with no commercial motive, its employees’ desire to servepeople suffering during these crises stimulated innovations thatlater benefited the company.
Or Proctor & Gamble. Despite a decade-long commitment toresearch and development of a water purification product,commercial prospects were unpromising. But because it was soconsistent with P&G’s statement of purpose, people within thecompany persevered. And when the tsunami struck, it was then ableto deliver roughly a billion glasses of drinking water for thevictims, earning plaudits from aid partners, the media,governments, and crucially, P&G employees.
SuperCorp captures the zeitgeist of the emergingtwenty-first-century business. For example:
? The strong potential synergy between financial performance andattention to community and social needs
? The unique competitive advantage from embracing the values andexpectations of a new generation of professionals
? The growth opportunities that result from stressing values andsupressing executive egos when seeking partners and integratingacquisitions
SuperCorp is a remarkable look at the business of the futureand the management skills required to get there. IBM, Banco Real,P&G, Cemex, Omron, and other companies reported on now movewith the rapidity and creativity of much smaller enterprises. Thesecompanies are not perfect, but when people are empowered and valuesdrive decisions, everything can come together in magical “Rubik’sCube moments” of deep satisfaction. Kanter’s compelling andinspiring stories show that people are more inclined to be creativewhen their company values innovation that helps the world.
【媒体评论】
“Rosabeth Moss Kanter puts a new and welcome human face on themany ways companies can serve a public purpose while alsoprospering financially and building an enduring culture ofsuccess.”
—Andrea Jung, chairman and CEO of Avon Products
“A brilliant report from the front lines of companies creating thefuture by accomplishing the seemingly impossible.”
—Daniel Vasella, chairman and CEO of Novartis
“Rosabeth Moss Kanter . . . breaks new ground in SuperCorpby envisioning the corporation of the future that creates long-termvalue through breakthrough strategies that help solve intractablesocial problems.”
—Bill George, former chairman and CEO of Medtronic and author ofTrue North
“This is the book that the world has been anxiously waiting for,perhaps Kanter’s most notable, certainly one of the most importantbooks of this decade.”
—Warren Bennis, University Professor at the University of SouthernCalifornia and author of On Becoming a Leader
“Kanter makes a compelling case about the role played by corporateculture, values-based decision making, and larger societal issuesin the creation of sustainable success.”
—Ivan Seidenberg, chairman and CEO of Verizon
“Innovative insights on how companies–and their leaders–can be atthe vanguard of the twenty-first century. . . . Timely,informative, and uplifting–all of the qualities of a greatread!”
—David Gergen, CNN senior political analyst and White Housecounselor to four U.S. presidents
“Kanter’s careful analysis goes beyond the platitudes by offeringsolid examples and important insights.”
—Samuel J. Palmisano, chairman, p?resident, and CEO of IBM
“Unless your business is also serving a social purpose you miss anopportunity for innovations that bring profits. Rosabeth MossKanter, one of our most outstanding scholars, excels in hercharacteristic manner by taking the lead and developing practicalideas for the leaders of the future.”
—Ram Charan, coauthor of Execution: The Discipline of GettingThings Done
作者: edited by Eric Francotte and Wolfgang Lindner.
简介:A growing number of pharmaceutical drugs are chiral (referring to a molecules that are non-superimposable upon their mirror-images) because of their unique pharmacological properties. Following a history of chirality in drugs, Francotte (director and head of separations, Novartis Institutes for BioMedical Research, Switzerland) and Lindner (analytical chemistry, U. of Vienna, Austria) present three chapters discussing synthesis of chiral drugs. An industrial perspective is given on the stereoselective synthesis of drugs, aspects of chirality in natural products drug discovery are examined, and biotransformation methods for preparing chiral drugs and drug intermediates are presented. The next five chapters discuss separations, offering treatments of resolution of chiral drugs and drug intermediates by crystallization, isolation and production of optically pure drugs by enantioselective (able to select one of a chiral pair) chromatography, stereoselective chromatographic methods for drug analysis, capillary electrophoresis coupled to mass spectrometry for chiral drugs analysis, and chiral molecular tools for preparation of enantiopure alcohols and simultaneous determination of their absolute configurations by x-ray crystallography or anisotrophy methods. The final chapter reviews software and literature research on chirality in modeling, chirality in docking, and chiral ligand-receptor interaction and symmetry. Annotation 漏2007 Book News, Inc., Portland, OR (booknews.com)
Decoding the genomic control of immune reactions /
作者: [editors, Gregory Bock and Jamie Goode].
简介:Judging from this collection of reports on recent research, great progress is being made toward using the genome sequences of humans, mice and other vertebrates to solve key problems in immunological disease and chronic infections. However, researchers are finding a barrier in the identification of key sequences and circuits controlling the relevant immune reactions. Drawn from material presented at the Novartis Foundation Symposium entitled "Decoding the Genomic Control of Immune Reactions" held in Canberra in March 2006, this collection covers transcriptional regulatory networks in macrophages, molecular pathways and their role in human disease, specifying the patterns of immune cell migration, human monogenic disorders and their relationship with specific infections, the genetic control of susceptibility to a strain of tuberculosis, disorders resulting from defective LAT signalosomes, smallpox and mousepox, strategies for phenotype detection and subsequent mapping and cloning, genetic control of host-pathogen interactions, systems genetics, and regulation of the immune system. Annotation 漏2007 Book News, Inc., Portland, OR (booknews.com)
简介: Peter Walker and Partners (PWP) was formed in 1983. Their projects, executed worldwide, vary both in scale and type: urban design and planning, corporate headquarters and university campuses, parks, plazas and gardens. Exploring the relationships between art, culture and context, Peter Walker re-forms the landscape - whether urban or natural - and challenges traditional concepts of design. This book features the company's work from the last seven years, all of which brilliantly showcases the firm's range. It includes sixteen built projects in Europe, Asia and the United States - parks, corporate headquarters, foundations, museums and urban plazas; seven works in progress, including the American Embassy in Beijing and the World Trade Center Memorial in New York City; and ten site planning and urban-design projects, among them millennium parklands in Sydney, Australia and Novartis Headquarters in Basel, Switzerland. The book opens with a short essay about the organization and philosophy of the office, the partners and associates, and the particular way that PWP practises the craft of landscape architecture. It concludes with four competitions, including one for 1600 Pennsylvania Avenue.
作者: (荷)冯·特姆彭纳斯(Fons Trompenaars),(英)查尔斯·汉普顿-特纳(Charles Hampden-Turner)著;陈文言译
出版社:中国人民大学出版社,2007
简介: 被管理大师汤姆·彼得斯誉为“一部惊世杰作”! 本书长期雄踞美国畅销书目榜,并风靡整个欧洲,被译成法、德、荷等多种文字 研究覆盖55个国家的大约50,000例有效样本,权威、可信。 7个维度解秘不同国家、区域、群体之间文化差异的“心灵程序” 4种公司文化囊括不同类型公司经营管理的制胜策略 6个职能部门反映深层文化差异引发职能间的矛盾冲突 对工作场所中的性别差异进行独到地剖析 本书着重讨论文化差异及其对经营管理的影响。撰写本书的目的不是为了让读者去理解解其他国家的人民。我们深信,一个人永远不能理解别的文化的人。已婚人士应该知道,即使是要完全理解一个本文化的人,也是不可能的。 正是在这样的背景下,我们开始思考:我们从那些当今世上最优秀的商学院那里所传承来的美国式管理技巧和哲学,在世界其他国家(或地区),是否都能行得通呢? 书中所描绘的不同文化取向是两位作者从15年的案头研究和实务操作中总结出来的。引用案例一方面取材于我们提供过的跨文化培训项目,总计1000余例、覆盖20多个国家;一方面来源于对30个跨国公司的实证研究。这些公司包括阿克苏公司(AKZO)、先进微器件公司(AMD)、美国电话电报公司(AT&T)、巴安公司(Baan Software)、埃尔夫阿基坦公司(Elf Aquitaine)、SGS-汤姆逊微电子公司(SGS/Thomson)、葛兰素公司(Glaxo)、喜力(Heineken)、卜内门化学工业有限公司(ICI)、应用材料公司(Applied Materials)、美斯公司 (Mars)、摩托罗拉公司(Mortorola)、飞利浦公司(philips)、荷兰皇家航空公司(Royal Dutch Airlines KLM)、荷兰皇家壳牌石油公司(the Royal Dutch/Shell Group)、半导体制造技术公司(Sematech)、天合公司(TRW)、范李尔公司(Van leer)、沃尔沃公司(Volvo)和诺华公司(Novartis)等,其分支结构覆盖了全球50多个国家。研究中隐去了多数案例公司的真实名称。为保证样本的可比性,我们在有上述公司营运机构的每个国家,都选取了至少100个背景和职业相似的实验对象。其中,大致75%的对象属于管理层(如执行经理、营销经理等),而剩余的25%则属于普通行政人员(如打字员、速记员、秘书等)。目前,我们的数据库已涵盖3万个实验对象,是本书第一版4年前出版时的2倍之多。实证结果有力的证明了我们的观点。 本书力图做到三件事:消除 “有一种最好的管理和组织方式”的论调;通过学习如何认识和应对商务经营中的文化差异,让读者更清楚的认识自己的文化并对不同文化之间的差异有总体认识;为国际公司解决“全球化”与“本土化”的两难冲突提供文化视角。本书最关注的是第二件事。我们认为,了解我们自己的文化并了解其他人的思考、行为模式是取得成功的基础。
True North: Discover Your Authentic Leadership 9780787987510
作者: Bill W. George ,(比尔·W·乔治),Peter E. Sims ,(彼特·E·西姆斯) 著
出版社:Wiley 2007年04月
简介: Bill George is professor of management practice at the Harvard Business School and former chairman and CEO of Medtronic, the world's leading medical technology company. Under his leadership, Medtronic's market capitalization grew from $1.1 billion to $60 billion, averaging 35 percent a year. He is the author of the best-selling Authentic Leadership and a board member of Goldman Sachs, Target, and Novartis. George has been recognized as Executive of the Year by the Academy of Management Director of the Year by the National Association of Corporate Directors, and one of Public Broadcasting's Top 25 Leaders of the Past 25 Years. Peter Sims established Leadership Perspectives, a class on leadership development at the Stanford Graduate School of Business, and cofounded the London office of Summit Partners, a leading investment firm. He was also part of the Deloitte Touche Tomatsu Global Strategy Team and has contributed to numerous publications including the Harvard Business Review.
简介:Summary: Publisher Summary 1 Protein tyrosine kinases (PTKs) function as components of signal transduction pathways and play a central role in the control of cell growth, metabolism, differentiation and apoptosis. Currently 20 different PTKs are being considered as potential therapeutic targets in oncology. In this collection of 11 articles, contributors describe their work in PTKs in such areas as using PTKs as targets for cancer and other indications, targeting Src homology 2 domains in drug discovery, using P12-kinase inhibition as a target for therapeutic intervention, using an activated FLT3 receptor tyrosine kinase as a therapeutic target in leukemia and JAK kinases in leukemia, lymphomas and multiple myeloma, applying platelet-derived growth factor, using a targeted therapy for myelogenous leukemia, testing signal transduction inhibitors in animal models of cancer, and using phosphoproteomics in drug discovery and development. Annotation 漏2005 Book News, Inc., Portland, OR (booknews.com) Publisher Summary 2 Leading researchers, from the Novartis group that pioneered Gleevec/Glivec鈩?and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of resistance, etc.) aimed at generating PTK inhibitors for the treatment of various diseases, including cancer. Highlights include a discussion of the rationale and the progress made towards generating "selective" low molecular-weight kinase inhibitors; an analysis of the normal function, role in disease, and application of platelet-derived growth factor antagonists; and a summary of the factors involved in successful structure-based drug design. Additional chapters address the advantages and disadvantages of in vivo preclinical models for testing protein kinase inhibitors with antitumor activity and the utility of different methods in the drug discovery and development process for determining "on-target" vs "off-target" effects of kinase inhibitors.
简介:"Computational Approaches in Cheminformatics and Bioinformatics explores for the first time the unique connection between cheminformatics and bioinformatics. This revolutionary resource demonstrates how integrating these two seemingly different disciplines allows one to computationally address discovery and identification of biological systems in relation to future development. Additionally, the book includes insights from experts from public (NIH), academic, and industrial sources (Novartis, Pfizer). Scientists will find this ground-breaking book essential to the advancement of drug discovery and the issue of chemical control and manipulation of such systems"--
简介:Due to the dramatic shifts in the knowledge economy, this book provides a significant departure from traditional strategic management concepts and practice. Designed for both advanced students and business managers, it presents a unique combination of new strategic management theory, carefully selected strategic management articles by prominent scholars such as Gary Hamel, Michael Porter, Peter Senge, and real-world case studies. On top of this, the authors link powerful new benchmarks in strategic management thinking, including the concepts of Socio-Cultural Network Dynamics, Systemic Scorecards, and Customer Knowledge Management with practical business challenges and solutions of blue-chip companies with a superior performance (Lafite-Rothschild, Who's Who, Holcim, BRL Hardy, Kuoni BTI, Deutsche Bank, Unisys, Novartis).
简介: An ideal introduction to the pharmaceutical industry, this book describes the process of bringing a new drug to the marketplace. It explains why, although thousands of compounds show initial promise, only a small handful will be developed for human clinical trials and perhaps only one will become an approved drug. Describing the huge complexities involved, it shows how new molecular understanding and techniques can make the process more targeted and successful. * Includes the new molecular techniques of drug design and development. * Discusses current therapeutic needs. * Covers pharmacoepidemiology and pharmacoeconomics. * Edited by Humphrey Rang, who is also known throughout the world as a co-author of the enormously successful and authoritative textbook, Pharmacology, now in its fifth edition. * Foreword by Daniel Vasella, CEO, Novartis International. * Includes contributors from both the pharmaceutical industry and universities.
Architecture and urbanism.035,Novartis campus
作者: 阮海洪主编;《建筑与都市》中文版编辑部编;陈霜,肖靖译
出版社:华中科技大学出版社,2011
简介: 在瑞士的巴塞尔,有一处“诺华园”,堪称建筑仙境。该园区是跨国集团诺华制药公司的企业基地。其中,由迪纳与迪纳建筑师事务所、彼德·马克利建筑师事务所和SANAA 建筑师事务所设计的项目,已被多家建筑杂志(包括a+u 在内)进行过专题介绍。之后,分别由拉斐尔·莫尼奥和槙文彦主持设计的建筑项目于2009 年完工;谷口吉生、大卫·奇普菲尔德、安?忠雄和弗兰克·盖里的建筑作品则于2010 年面世;而阿尔瓦罗·西扎和艾德瓦尔多·索托·德·莫拉所设计的建筑预计于2011 年竣工。不难想象,由这样一批具有国际声誉的建筑大师担纲设计,诺华园内所有建筑都是一流水准的。园区的每个角落都经过精心规划,包括所有的广场、街道和花园。然而,诺华园既不是建筑博览会,也不是迪士尼乐园那样的主题游乐场,而是为诺华员工所建的办公室和实验室。 诺华园的原址为工业厂区,始建于19 世纪下半叶,历经变革。直至大约10 年前,园区推出重建计划,前景宏伟,旨在将该生产制造基地转型成为?处“知识园区”。本期介绍了诺华园2010 年的概况,并详细介绍了各个建筑项目。项目照片拍摄于2010 年7 月。负责园区总体规划的建筑师维托里奥·马尼亚戈·兰普尼亚尼为本刊撰写了一篇相关文章,兰普尼亚尼还承担设计了园区中的一座单体项目。另外,本期还介绍了诺华园的历史以及园区的景观设计、公共艺术及生态环保等方面的内容。 今天的诺华园仍在建设之中。诺华制药公司将该园区项目视为一项涵盖建筑、景观和可持续性发展等多个层面的企业发展战略,并将在未来持续深化发展。我们期待着该项目为新型办公场所带来更多可能性。
简介:In times of economic and financial crises, the content of this book rings true. While we often look at formal compliance procedures, incentive systems and other 鈥榯echnical鈥?ways to ensure effective internal control, this study emphasizes a different perspective: How do the management principles and practices influence organizational culture in order to enhance control effectiveness? New theory is provided on the way that tone at the top 鈥?leadership, sustainability, accountability, and other social control aspects 鈥?is combined with formal control. The research is based on in-depth interviews with senior-level people (e.g. executives, managers, auditors) from more than 18 renowned U.S. and Swiss companies, and theory from fields of sociology and social psychology. In contrast to contemporary accounting and control research, where culture provides a context for control, here any control mechanism can in turn influence culture. The study offers innovative insights for both academics and practitioners including: a) a new research framework for analyzing the links between culture and control; b) statements from senior-level people of eBay, Google, Hewlett Packard, Intel, Levi Strauss & Co., Microsoft, Motorola, Novartis and many more; c) a practice-oriented tool to proactively mitigate typical roots of internal control failures; d) integrated theory on social systems, personal and organizational values and organizational corruption; e) a foreword from Solomon N. Darwin, University of California at Berkeley.
简介:MANAGING HUMAN RESOURCES THROUGH STRATEGIC PARTNERSHIPS, Tenth Edition, explains how successful companies manage human resources in order to compete effectively in a dynamic, global environment. Long known and respected as a tightly integrated, clear, higher-level text, MANAGING HUMAN RESOURCES THROUGH STRATEGIC PARTNERSHIPS, Tenth Edition, presents strong organizing themes: strategy, teams, diversity, global issues, and change. These themes are highlighted in interesting boxed features throughout the tenth edition. The text also follows an organizational structure that emphasizes the HR Triad (employee, line manager, HR manager) with the understanding that effective human resource management requires mutual understanding and collaboration among HR professionals, managers, and all other employees. Because organizations differ from each other in so many ways--including their locations, competitive strategies, products and services, and corporate cultures--these experienced authors use many different companies to illustrate how employers address the challenge of managing human resources effectively. Examples of companies in many different industries include Southwest Airlines, Deere & Company, Wegmans, Lincoln Electric, McDonalds, TRW, Steelcase, Google, Novartis, Johnson & Johnson, SAS, Outback Steakhouses, United States Postal Service, UPS, IBM, 3M, Alberto Culver Weyerhaeuser, The Ritz-Carlton, and many others. The authors selected these organizations because they successfully combine a respect for established principles of human resource management with a willingness to experiment and try new approaches, allowing them to succeed year after year.
简介:Summary: Publisher Summary 1 Gremlich (Optical Spectroscopy Laboratory, Novartis Pharma AG) and Yan (analytical chemistry, ChemRx Advanced Technologies, Inc.) supply chemical and structural information for identifying and characterizing biological molecules. The 13 contributions provide a thorough introduction to the new methodologies in infrared and Raman instrumentation as well as to their biological applications for future use in both academic and industrial environments. They integrate the biological targets with research experience in order to discuss topics such as the variety of uses for vibrational optical activity and vibrational spectroscopic mapping and imaging; clinical applications; the advantages obtained by time-resolved step scan, surface-enhanced, and imaging approaches; the latest software developments affecting biomedical diagnosis, such as artificial neural networks; and others. Contains b&w and color images and diagrams. Annotation c. Book News, Inc., Portland, OR (booknews.com)
简介:Many leaders are unaware of the amazing power of questions. Our conversations may be full of requests and demands, but all too often we are not asking for honest and informative answers, and we don't know how to listen effectively to responses. When leaders start encouraging questions from their teams, however, they begin to see amazing results. Knowing the right questions to ask--and the right way to listen--will give any leader the skills to perform well in any situation, effectively communicate a vision to the team, and achieve lasting success across the organization. Thoroughly revised and updated, Leading with Questions will help you encourage participation and teamwork, foster outside-the-box thinking, empower others, build relationships with customers, solve problems, and more. Michael Marquardt reveals how to determine which questions will lead to solutions to even the most challenging issues. He outlines specific techniques of active listening and follow-up, and helps you understand how questions can improve the way you work with individuals, teams, and organizations. This new edition of Leading with Questions draws on interviews with thirty leaders, including eight whose stories are new to this edition. These interviews tell stories from a range of countries, including Singapore, Guyana, Korea, and Switzerland, and feature case studies from prominent firms such as DuPont, Alcoa, Novartis, and Cargill. A new chapter on problem-solving will help you apply questions to your toughest situations as a leader, and a new "Questions for Reflection" section at the end of each chapter will help you bring Marquardt's message into all of your work as a leader. Now more than ever, Leading with Questions is the definitive guide for becoming a stronger leader by identifying--and asking--the right questions.
简介: With its content stemming from tried and tested course notes, this book draws on the expertise from authors based at leading pharmaceutical companies such as Bayer, AstraZeneca and Novartis, as well as leading academic institutions. As such, it represents the perfect blend of theoretical background and application-oriented discussions, including the latest research developments and industrial examples. In the first section, the basic mechanisms are introduced, ensuring an understanding of supersaturation. In addition, the solubility of the substance and its dependences on process conditions and the various techniques of crystallization and their possibilities and limitations are discussed. The second part builds on the basics, exploring how crystallization processes can be developed, either batch-wise or continuous, from solution or from the melt. The two sections are bridged by a discussion of the purification during crystallization, where practical aspects and an insight using theoretical concepts are combined. The third part of the book is dedicated to accounts of actual developments and successful crystallizations, outlining typical pitfalls and strategies to avoid them, as well as to the design of robust processes.
简介:Summary: Publisher Summary 1 While we often look at formal compliance procedures, incentive systems and other 'technical' ways to ensure effective internal control, this study emphasizes a different perspective: How do the management principles and practices influence organizational culture in order to enhance control effectiveness? Publisher Summary 2 In times of economic and financial crises, the content of this book rings true. Drawing from interviews with executives, senior managers and/or auditors from renowned companies (eBay, Google, Hewlett Packard, Intel, Levi Strauss & Co., Microsoft, Novartis and many others) and theory from fields of sociology and social psychology, this research study provides an understanding of how "tone at the top" imprints on an organization and why that imprint works. More specifically, it discusses how managers' principles and practices can actively shape an open-minded culture that enhances effective internal control.
热门推荐
Netter’s illustrated human pathology
作者: L. Maximilian Buja,Gerhard R. F. Krueger原著;Frank H. Netter绘图;崔全才主译



















